Sr. Director, Patient Marketing Dual Asset Strategy

Job description

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. The Senior Director, Patient Marketing & Commercial Strategy MMN-CIDP Franchise is a senior commercial leader accountable for maximizing growth of Vyvgart Hytrulo in CIDP while strategically preparing for and integrating the launch of Empa in MMN and subsequently CIDP, within a multi-indication therapeutic franchise. This role sits on the CIDP Indication Strategy Team and JIST, and owns the patient commercial strategy across the portfolio, with primary respon...